[1]
K. Tewthanom and W. Jongjaroenprasert, “THE PHARMACOKINETICS OF 2 DOSES (50 µG AND 100 µG) LEVOTHYROXINE TREATMENT IN ATHYREOTIC PATIENTS”, Int J App Pharm, vol. 8, no. 4, pp. 66–68, Oct. 2016.